Gateway for Cancer Research
Gateway for Cancer Research
Explore linked clinical trials.32 results ยท Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-10-09 | NCT02754752 | |
| TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer | primary peritoneal carcinoma | Active, not recruiting | Early phase 1 | 2026-10-06 | NCT05053750 | |
| Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute biphenotypic leukemia, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2026-10-06 | NCT04898894 | |
| Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial | Neoplasms by Histologic Type, adenocarcinoma, adenoid cystic carcinoma, carcinoma, epithelial neoplasm, neoplasm | Recruiting | Not applicable | 2026-10-05 | NCT04883671 | |
| Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, bladder transitional cell carcinoma, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Phase 2 | 2026-10-01 | NCT06263153 | |
| A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-09-30 | NCT02344355 | |
| Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy | anxiety disorder, depressive disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-09-11 | NCT06200155 | |
| PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, hormone receptor-positive breast cancer, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-08-26 | NCT07222215 | |
| ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma | Hemic and Lymphatic Diseases, Hodgkin Lymphoma, Adult, Hodgkins lymphoma, Neoplasms by Histologic Type, classic Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-08-20 | NCT07021989 | |
| RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm | Recruiting | Phase 2 | 2026-08-18 | NCT07735624 | |
| Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1 | Clonal Cytopenia of Undetermined Significance | Active, not recruiting | Phase 2 | 2026-08-12 | NCT05030441 | |
| STOP-HER2: Stopping Trastuzumab in HER2+ MBC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-08-06 | NCT05721248 | |
| The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, skin disorder | Active, not recruiting | Phase 2 | 2026-08-05 | NCT05458284 | |
| Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 1 / Phase 2 | 2026-08-05 | NCT05318469 | |
| EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors | Advanced Malignant Solid Neoplasm | Active, not recruiting | Phase 1 | 2026-07-21 | NCT01591356 | |
| Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, bone disorder, connective tissue neoplasm, melanocytic neoplasm, melanoma, musculoskeletal system disorder, neoplasm, neuroendocrine neoplasm, osteosarcoma, primitive neuroectodermal tumor, sarcoma, skin disorder, skin neoplasm, urinary system disorder | Recruiting | Phase 1 | 2026-07-15 | NCT03093909 | |
| Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, atypical teratoid rhabdoid tumor, chordoma, mixed neoplasm, neoplasm, rhabdoid tumor, rhabdoid tumor of the kidney, sarcoma | Active, not recruiting | Phase 2 | 2026-07-01 | NCT04416568 | |
| Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Not yet recruiting | Phase 1 / Phase 2 | 2026-06-24 | NCT07217990 | |
| Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-24 | NCT02553460 | |
| CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 1 | 2026-06-17 | NCT05029999 | |
| Personalized Autologous Transplant for Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 | 2026-06-15 | NCT04483206 | |
| PH 2 Pemigatinib in SDH-deficient GIST | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, gastrointestinal stromal tumor, neoplasm | Recruiting | Phase 2 | 2026-05-22 | NCT07434843 | |
| Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas | KRAS Gene Mutation | Active, not recruiting | Phase 2 | 2026-05-22 | NCT03808558 | |
| ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-05-18 | NCT03587740 | |
| A Study of Surgery and Radiotherapy in People With Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-05-14 | NCT07053085 |